Medscape www.medscape.com

Tables for:
Daily Dose versus Alternate-Day Dosing of Simvastatin in Patients With Hypercholesterolemia

[Pharmacotherapy 22(9):1110-1116, 2002. © 2002 Pharmacotherapy Publications]


Table 1. Goals for Low-Density Lipoprotein Cholesterol Levels[2, 4, 14]


RiskLDL Goal
(mg/dl)
Without CHD and with 0-1 risk factor< 160
Without chd and with 2 or more risk factors< 130
With CHDa, b< 100

CHD = coronary heart disease.
aSee Table 2 for risk factor assessment.
bAccording to the American Diabetes Association (ADA) guidelines and 2001 National Cholesterol Education Program guidelines, the recommended LDL level for patients with diabetes is < 100 mg/dl. However, when patients were enrolled in this study, the 2001 NCEP guidelines were not published, and Bay Pines Veterans Affairs Medical Center PharmCare clinic treated these patients according to the ADA goal of < 100 mg/dl.

Table 2. Major Risk Factors Used to Calculate Low-Density Lipoprotein Cholesterol Goals[2, 4]


Positive risk factors
   Age
      Men >/= 45 yrs
      Women >/= 55 yrs or premature menopause without
      estrogen replacement therapy
   Family history of premature CHD (definite myocardial
      infarction or sudden death before 55 yrs of age in father
      or other male first-degree relative, or before 65 years of
      age in mother or other female first-degree relative)
   Current cigarette smoking
   Hypertension (blood pressure >/= 140/90 mm Hg or taking
   antihypertensive drug)
   Low HDL level (< 35 mg/dl)a
Negative risk factor
   High HDL level (>/= 60 mg/dl)

CHD = coronary heart disease; HDL = high-density lipoprotein cholesterol.
a2001 National Cholesterol Education Program guidelines recommend that an HDL level of < 40 mg/dl be considered a risk factor.

Table 3. Low-Density Lipoprotein Cholesterol Levels of Study Patients


LDL Level (mg/dl)Change
NCEP
Goala
ADA
Goala
Daily
Simvastatin
Alternate-Day
Simvastatin
< 160NAb136129-7
< 130< 10010681c-25c
< 130NAb113135d+22d
< 130< 1009297+5
< 100NAb88110+22
< 100NAb9682-14
< 100NAb8589+4
< 100< 1008795+8
< 100< 1008982-7
< 130NAb8070d-10d
< 100NAb9679-17
< 100NAb9781-16
< 130< 1009691e-5e
< 130< 10098NAfNAf
< 100NAb7067-3

LDL = low-density lipoprotein cholesterol; NCEP = National Cholesterol Education Program; ADA = American Diabetes Association; NA = not applicable.
aDuring study enrollment, 2001 NCEP guidelines were not published, and the 1993 NCEP goal of < 100 mg/dl did not include diabetes as a major risk factor for development of coronary artery disease. However, study patients with diabetes were treated according to the ADA goal of < 100 mg/dl.[2, 4, 14]
bPatient did not have diabetes.
cPatient increased caloric intake during treatment period.
dPatient was noncompliant.
ePatient ate more healthful foods and fewer snacks during treatment period.
fPatient dropped out of the study.

Table 4. Relevant Laboratory Values in Patients Taking Simvastatin Daily versus Every Other Day


 Daily
Simvastatin
Alternate-Day
Simvastatin
p ValueNormal
Range
AST (U/L)25.2 ± 5.91 24.4 ± 4.6 0.495-60
ALT (U/L)17.3 ± 6.2 15.93 ± 6.8 0.617-56
Creatine kinase (U/L)72.1 ± 35.1 70.3 ± 54 0.6555-170
Total cholesterol (mg/dl)167 ± 21.8165 ± 270.66 
Triglycerides (mg/dl)121 ± 45.7140.8 ± 46.90.1 
LDL (mg/dl)95.3 ± 15.292 ± 20.20.43 
HDL (mg/dl)48.4 ± 12.545.4 ± 9.50.24 

AST = aspartate aminotransferase; ALT = alanine aminotransferase; LDL = low-density lipoprotein cholesterol; HDL = high-density lipoprotein cholesterol.
Values are mean ± SD.

Table 5. Cost Savings with a 30-Day Supply of Simvastatin for Alternate-Day Dosing versus Daily Dosing[18]


Daily DosingAlternate-Day Dosing Savings ($)
Dose (mg)AWP ($)Dose (mg)AWP ($)
553.421035.7517.67
1071.592062.459.14
20124.904062.45 62.45
40 124.908062.4562.45
80124.90NAaNAaNAa

AWP = average wholesale price.
a160 mg is above the maximum recommended single daily dose of simvastatin, even if taken every other day.